Riferimento farmaci
Nifurtimox
Nifurtimox is a medicine in the class anti parasitic.
- Classe del farmaco: Anti Parasitic
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Anti Parasitic
- Forme farmaceutiche comuni
- compressa
- Nomi commerciali
- 1
- Paesi e mercati
- 1
Come agisce
Mechanism not fully understood. Nifurtimox is activated by type I and type II nitroreductases, producing toxic intermediate metabolites and/or reactive oxygen species that induce DNA damage and cell death of intracellular and extracellular T. cruzi.
Gravidanza e allattamento
- Gravidanza
- Unsafe May cause fetal harm based on animal studies; treatment of chronic Chagas disease in pregnancy not recommended; acute symptomatic disease requires case-by-case risk-benefit evaluation.
- Allattamento
- Unknown Nifurtimox is present in breast milk (estimated infant dose less than 15% of the pediatric daily dose); monitor infants for vomiting, rash, decreased appetite, pyrexia and irritability; weigh benefits of breastfeeding against maternal need.
Effetti indesiderati segnalati
- Vomiting
- Abdominal pain
- Headache
- Decreased appetite
- Nausea
- Pyrexia
Controindicazioni
- Known hypersensitivity to nifurtimox or any excipients
- Alcohol consumption during treatment
Chi deve prestare attenzione
- Genotoxicity demonstrated in humans, in vitro and in rodents; carcinogenicity in humans unknown.
- Embryo-fetal toxicity: can cause fetal harm; pregnancy test before treatment; effective contraception during treatment and for 6 months after; males use condoms during and for 3 months after.
- May worsen neurological and psychiatric conditions (brain injury, seizures, psychiatric disease); use under close medical supervision.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Nifurtimox: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Nifurtimox used for?
Nifurtimox is a medicine in the class anti parasitic.
What side effects have been reported with Nifurtimox?
Vomiting, Abdominal pain, Headache, Decreased appetite, Nausea, Pyrexia.
Can Nifurtimox be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. May cause fetal harm based on animal studies; treatment of chronic Chagas disease in pregnancy not recommended; acute symptomatic disease requires case-by-case risk-benefit evaluation. Breastfeeding: Unknown. Nifurtimox is present in breast milk (estimated infant dose less than 15% of the pediatric daily dose); monitor infants for vomiting, rash, decreased appetite, pyrexia and irritability; weigh benefits of breastfeeding against maternal need.
What does Nifurtimox interact with?
MediHelp does not list a checked interaction for Nifurtimox yet. Always tell your pharmacist about every medicine you take.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
